Free Practice Questions for UKOM Sp.JP

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card

100+ Questions

100% Free

Loading practice questions...

Same family resources

Explore More Indonesia Medical Specialist Competency Examinations (Ukom Kolegium Spesialis)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

UKOM Sp.A — Uji Kompetensi Dokter Spesialis Anak (Indonesia)

Practice Questions100 questions

UKOM Sp.An — Uji Kompetensi Dokter Spesialis Anestesiologi dan Terapi Intensif (Indonesia)

Practice Questions100 questions

UKOM Sp.B — Uji Kompetensi Dokter Spesialis Bedah (Indonesia)

Practice Questions100 questions

UKOM Sp.DVE — Uji Kompetensi Dokter Spesialis Dermatologi, Venereologi, dan Estetika (Indonesia)

Practice Questions100 questions

UKOM Sp.F.M — Uji Kompetensi Dokter Spesialis Forensik dan Medikolegal (Indonesia)

Practice Questions100 questions

UKOM Sp.KJ — Uji Kompetensi Dokter Spesialis Kedokteran Jiwa (Indonesia)

Practice Questions100 questions

Exam Review

Key Facts: UKOM Sp.JP Exam

Not published

Official CBT item count

Kolegium Jantung NBOE

Not published

OSCE station count

Perkonsil No. 57/2018

25 of 100

CAD and ACS questions in this practice bank

OpenExamPrep

4–5 Years

Residency Training

PPDS Sp.JP Indonesia

Not published

National first-attempt pass rate

Kolegium Jantung published data

100 MCQs

Practice Adaptation Bank

OpenExamPrep

The UKOM Sp.JP is the mandatory national board certification examination conducted by Kolegium Jantung dan Pembuluh Darah Indonesia and KKI for cardiology residency graduates to attain specialist credentialing (Sp.JP) and specialist STR registration. Tested under Perkonsil No. 57/2018 standards across CBT multiple-choice and OSCE stations, the curriculum spans acute coronary syndromes, heart failure, arrhythmias, valvular disorders, vascular medicine, and prevention. Note: This question bank is an independent English-language MCQ study adaptation created by OpenExamPrep for self-assessment.

Sample UKOM Sp.JP Practice Questions

Try these sample questions to review concepts for the UKOM Sp.JP exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 54-year-old man presents to the emergency department of a tertiary hospital with 2 hours of crushing retrosternal chest pain radiating to the left arm and jaw. An ECG reveals 3 mm ST-segment elevation in leads II, III, and aVF with reciprocal depression in leads I and aVL. The cardiac catheterization laboratory is on-site and fully staffed. According to national and international STEMI guidelines, what is the recommended target door-to-balloon time for primary percutaneous coronary intervention (primary PCI)?

A.Within 60 minutes from hospital presentation

B.Within 90 minutes from first medical contact

C.Within 120 minutes from symptom onset

D.Within 30 minutes from emergency department arrival

Explanation: For patients with ST-segment elevation myocardial infarction (STEMI) presenting directly to a PCI-capable facility, the guideline-recommended reperfusion benchmark is a door-to-balloon (or first medical contact-to-device) time of ≤90 minutes. Prompt mechanical reperfusion within this window salvages ischemic myocardium, preserves left ventricular systolic function, and significantly reduces mortality.

2A 48-year-old woman presents to a community hospital in rural Indonesia without catheterization facilities with 90 minutes of acute chest pain. An ECG demonstrates 4 mm ST-segment elevation in leads V1–V4. The nearest PCI center is 3 hours away by ambulance. Intravenous tenecteplase is administered within 25 minutes of arrival. Ninety minutes post-fibrinolysis, her chest pain has resolved and ST segments have decreased by >70%. What is the most appropriate next management step under the pharmacoinvasive strategy?

A.Immediate emergent transfer for rescue PCI within 60 minutes

B.Routine transfer for diagnostic coronary angiography between 2 and 24 hours post-lysis

C.Conservative medical therapy with discharge after 48 hours without routine invasive angiography

D.Repeat intravenous fibrinolytic bolus at 4 hours to prevent early re-occlusion

Explanation: Under the pharmacoinvasive strategy for STEMI, patients who exhibit successful reperfusion post-fibrinolysis (>50% ST resolution and symptom relief at 60–90 minutes) should undergo routine transfer for coronary angiography and intervention within 2 to 24 hours. This planned early invasive strategy prevents recurrent re-infarction and improves outcomes without the increased bleeding risk of immediate instrumentation.

3A 62-year-old man with an anterior STEMI complicated by cardiogenic shock (SCAI Stage D: BP 78/46 mmHg, heart rate 118 bpm, cold extremities, oliguria, lactate 4.8 mmol/L) undergoes emergency coronary angiography. Angiography reveals an acute thrombotic total occlusion of the proximal left anterior descending (LAD) artery, a 90% stenosis in the mid-right coronary artery (RCA), and an 80% stenosis in the circumflex artery. Based on the CULPRIT-SHOCK trial and current guidelines, what is the best revascularization strategy during the index primary PCI procedure?

A.Immediate multi-vessel PCI of the LAD, RCA, and circumflex lesions in the index procedure

B.PCI of the culprit LAD lesion only, deferring non-culprit lesions to a staged setting

C.Immediate emergency coronary artery bypass grafting (CABG) without performing PCI

D.Balloon angioplasty of all three vessels without stent implantation to minimize procedure time

Explanation: The landmark CULPRIT-SHOCK randomized trial demonstrated that in patients with acute myocardial infarction and cardiogenic shock with multivessel disease, routine immediate multivessel PCI during the index procedure significantly increased 30-day mortality and renal replacement therapy compared to culprit-lesion-only PCI. Therefore, primary PCI should be confined to the culprit vessel (LAD), with staged revascularization of non-culprit vessels considered only after hemodynamic stabilization.

4On day 4 post-anterior STEMI, a 65-year-old woman experiences sudden respiratory distress and hypotension (BP 82/50 mmHg). Physical examination reveals a new harsh, loud holosystolic murmur best heard at the left lower sternal border accompanied by a palpable systolic thrill. Right heart catheterization reveals a step-up in oxygen saturation from the right atrium (62%) to the right ventricle (84%). What mechanical complication of myocardial infarction has occurred?

A.Papillary muscle rupture causing acute mitral regurgitation

B.Ventricular septal rupture (VSR)

C.Left ventricular free wall rupture with tamponade

D.Right ventricular infarction with acute tricuspid regurgitation

Explanation: Ventricular septal rupture (VSR) is characterized by a harsh holosystolic murmur with a palpable thrill along the lower left sternal border and an oxygen saturation step-up (≥7–10%) between the right atrium and right ventricle or pulmonary artery due to left-to-right shunting. In contrast, papillary muscle rupture produces an apical systolic murmur without an oxygen saturation step-up.

5A 58-year-old man presents with acute inferior STEMI and undergoes successful PCI of the right coronary artery (RCA). On hospital day 3, he abruptly develops severe dyspnea, orthopnea, and pulmonary edema with a systolic BP of 80 mmHg. Auscultation reveals a soft early-to-mid systolic murmur at the cardiac apex radiating to the axilla and sternum, with a prominent third heart sound. Transthoracic echocardiography demonstrates a flail mitral leaflet with severe eccentric regurgitation. Which anatomical structure is most likely disrupted?

A.Anterolateral papillary muscle supplied by dual blood supply from LAD and LCx

B.Posteromedial papillary muscle supplied solely by the posterior descending artery (PDA)

C.Chordae tendineae of the anterior leaflet due to chordal calcification

D.Aortic root and non-coronary cusp commissure

Explanation: The posteromedial papillary muscle has a single vascular supply, typically the posterior descending artery (PDA) from the dominant right coronary artery (or left circumflex), making it uniquely vulnerable to complete ischemic rupture during inferior or posterior infarctions. The anterolateral papillary muscle receives a dual blood supply from both the LAD and LCx diagonal/obtuse marginal branches and is less susceptible to rupture.

6A 71-year-old hypertensive female on post-infarction day 5 of an untreated anterior STEMI suddenly becomes unresponsive. The cardiac monitor displays sinus tachycardia at 125 bpm, but carotid and femoral pulses are non-palpable. Transthoracic echocardiography demonstrates massive pericardial effusion with right atrial and right ventricular diastolic collapse. What is the most definitive emergency treatment for this condition?

A.Intravenous bolus of tissue plasminogen activator (tPA)

B.High-dose intravenous epinephrine and bicarbonate infusion

C.Immediate transfer for surgical repair, with cautious image-guided pericardial drainage only if needed as a bridge

D.Immediate placement of an intra-aortic balloon pump via femoral artery

Explanation: This patient has post-infarction ventricular free-wall rupture with hemopericardium and tamponade. Emergency surgical repair is definitive. Pericardial drainage may be a carefully controlled bridge when profound tamponade prevents survival to surgery, but abrupt complete decompression can increase bleeding and must not delay operative care.

7Which of the following clinical variables is an official component of the Thrombolysis in Myocardial Infarction (TIMI) risk score for Unstable Angina and Non-ST-Elevation Myocardial Infarction (NSTE-ACS)?

A.Systolic blood pressure <100 mmHg on admission

B.Prior coronary artery bypass graft surgery (CABG)

C.Use of aspirin in the preceding 7 days

D.Elevated serum brain natriuretic peptide (BNP) level

Explanation: The TIMI risk score for NSTE-ACS consists of 7 historical and clinical predictors: (1) Age ≥65 years, (2) ≥3 conventional CAD risk factors, (3) Known CAD with ≥50% stenosis, (4) Aspirin use in the past 7 days, (5) Severe angina (≥2 episodes in last 24 hours), (6) ST-segment deviation ≥0.5 mm on ECG, and (7) Elevated serum cardiac biomarkers (troponin or CK-MB). Each variable contributes 1 point.

8A 66-year-old man presents with non-ST-elevation myocardial infarction (NSTEMI) characterized by dynamic T-wave inversions and elevated high-sensitivity cardiac troponin I. His GRACE risk score is calculated at 152 (high risk). He remains hemodynamically stable without recurrent chest pain or heart failure. According to current European Society of Cardiology (ESC) and Indonesian Heart Association (PERKI) guidelines, what is the recommended timing for invasive coronary angiography?

A.Immediate invasive strategy within 2 hours of presentation

B.Early invasive strategy within 24 hours of hospital admission

C.Selective invasive strategy only if non-invasive stress testing demonstrates ischemia

D.Delayed invasive strategy between 48 and 72 hours post-admission

Explanation: Current guidelines recommend an early invasive strategy (within 24 hours) for high-risk NSTE-ACS patients, defined by criteria including an established diagnosis of NSTEMI based on troponin elevation, dynamic ST/T-wave changes, or a GRACE risk score >140. An immediate invasive strategy (<2 hours) is reserved for very high-risk criteria (hemodynamic instability, cardiogenic shock, refractory angina, or life-threatening arrhythmias).

9A 52-year-old man with no prior medical history undergoes successful primary PCI with a second-generation drug-eluting stent for an acute anterior STEMI. He weighs 75 kg. He has no history of stroke, transient ischemic attack (TIA), or major bleeding. Which P2Y12 inhibitor regimen is preferred over clopidogrel for this patient, and what is its specific contraindication to screen for?

A.Prasugrel 10 mg daily (with a 60 mg loading dose); contraindicated in patients with a history of stroke or TIA

B.Ticagrelor 90 mg BID; contraindicated in patients with chronic kidney disease

C.Clopidogrel 75 mg daily; contraindicated in patients taking proton pump inhibitors

D.Cangrelor infusion for 12 months; contraindicated in patients over 50 years of age

Explanation: Potent P2Y12 inhibitors (prasugrel or ticagrelor) are superior to clopidogrel in reducing ischemic events and stent thrombosis post-PCI for ACS. In the TRITON-TIMI 38 trial, prasugrel significantly reduced cardiovascular death, MI, and stent thrombosis; however, it caused excess net harm (increased intracranial hemorrhage) in patients with a prior history of stroke or TIA, making prior stroke/TIA an absolute contraindication. In ISAR-REACT 5, prasugrel demonstrated superior efficacy compared to ticagrelor in ACS patients undergoing PCI.

10A 68-year-old woman with chronic non-valvular atrial fibrillation (CHA2DS2-VASc score of 4) is admitted with an acute NSTEMI and undergoes successful PCI with a drug-eluting stent. In accordance with the AUGUSTUS trial and modern antithrombotic consensus guidelines, what is the standard recommended antithrombotic regimen at the time of hospital discharge?

A.Triple therapy consisting of Warfarin, Aspirin, and Clopidogrel for 12 continuous months

B.Dual antithrombotic therapy consisting of a DOAC and Clopidogrel, stopping Aspirin at hospital discharge

C.Dual antiplatelet therapy consisting of Aspirin and Ticagrelor, discontinuing the DOAC until stent endothelialization is complete

D.Triple therapy consisting of Apixaban, Ticagrelor, and Aspirin for 6 months followed by DOAC monotherapy

Explanation: The landmark AUGUSTUS trial and current international/PERKI guidelines recommend dual antithrombotic therapy (a direct oral anticoagulant [DOAC] plus a P2Y12 inhibitor, preferably clopidogrel) as the standard default strategy for AF patients post-PCI. Aspirin is typically administered during the peri-procedural phase and discontinued upon hospital discharge (or up to 1 week), significantly reducing major bleeding complications without increasing ischemic or stent thrombosis events.

About the UKOM Sp.JP Exam

The UKOM Sp.JP (Uji Kompetensi Dokter Spesialis Jantung dan Pembuluh Darah) is the national exit examination administered by Kolegium Jantung dan Pembuluh Darah Indonesia for eligible physicians completing cardiology residency training. Current registration afterward follows the Konsil Kesehatan Indonesia and health-authority framework. Current sources confirm CBT and OSCE components but did not publish detailed station tasks.

Exam sponsor: Kolegium Jantung dan Pembuluh Darah Indonesia / KKI. The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

Question count not published by the exam provider

Time Limit

Three hours for the documented June 2026 CBT; confirm each sitting and OSCE schedule.

Passing Score

Not published in the official sources reviewed.

Exam / Certification Fees

Not published in the official sources reviewed.

Exam sponsor website

Reported exam pass rate: Not published in the official sources reviewed.. Not published in the official sources reviewed. Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Official sources

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

25%

Coronary Artery Disease & Acute Coronary Syndromes

Plaque rupture pathophysiology, STEMI door-to-balloon and door-to-needle time targets, pharmacoinvasive strategy, mechanical complications of MI (VSR, papillary muscle rupture, free wall rupture), NSTE-ACS risk stratification (TIMI, GRACE score), timing of invasive coronary angiography, DAPT regimens, and chronic coronary syndromes (CCTA, FFR/iFR, ISCHEMIA trial).

20%

Heart Failure, Cardiomyopathy & Shock

Four-pillar GDMT for HFrEF (ARNI, beta-blocker, MRA, SGLT2i), HFpEF diagnostic criteria (HFA-PEFF score), Stevenson acute heart failure profiles, diuretic resistance, cardiogenic shock SCAI stages A to E, vasoactive infusions (norepinephrine, dobutamine), mechanical circulatory support (ECMO, Impella), hypertrophic cardiomyopathy, amyloidosis, and myocarditis.

20%

Arrhythmias, Electrophysiology & Devices

Atrial fibrillation stroke risk (CHA2DS2-VASc), bleeding risk (HAS-BLED), DOAC reversal, early rhythm control (EAST-AFNET 4), catheter ablation, supraventricular tachycardias (AVNRT, WPW pre-excited AF contraindications), wide-complex tachycardia differentiation, channelopathies (LQTS, Brugada, CPVT), high-grade AV blocks, ICD primary prevention, and CRT indications.

15%

Valvular, Pericardial & Congenital Heart Disease

Severe aortic stenosis criteria, low-flow low-gradient AS dobutamine stress testing, TAVI vs SAVR indications, severe aortic regurgitation surgical triggers, rheumatic mitral stenosis Wilkins score and PMBC indications, secondary MR TEER (COAPT trial), infective endocarditis modified Duke criteria, acute pericarditis colchicine therapy, and adult CHD (ASD, PDA, Eisenmenger syndrome, repaired TOF).

20%

Vascular Medicine, Pulmonary Hypertension & Prevention

Hypertension diagnosis and staging per PERHI guidelines, single-pill combination therapy, resistant hypertension (PATHWAY-2 trial), secondary hypertension workup, hypertensive emergencies, acute aortic syndromes (Stanford A vs B, IMH), peripheral artery disease (ABI, CLTI, dual-pathway inhibition), DVT/PE risk stratification, pulmonary hypertension hemodynamic definitions, and dyslipidemia targets.

Preparing for the UKOM Sp.JP Exam

What You Need to Know

Passing score: Not published in the official sources reviewed.
Assessment: Question count not published by the exam provider
Time limit: Three hours for the documented June 2026 CBT; confirm each sitting and OSCE schedule.
Exam / certification fees: Not published in the official sources reviewed. Official sources

Using Our Practice Resources

Work through all 100 available questions
Review every answer and explanation
Track weak areas and revisit them
Use our AI tutor for tough concepts

UKOM Sp.JP: Suggested Study Strategy

1Master acute coronary syndrome reperfusion benchmarks: door-to-balloon time <=90 minutes for primary PCI in PCI-capable facilities, and door-to-needle time <=30 minutes for fibrinolysis followed by routine transfer within 2 to 24 hours under the pharmacoinvasive strategy.

2Memorize the four foundational pillars of HFrEF GDMT (ARNI, beta-blocker, MRA, SGLT2 inhibitor) and the mandatory 36-hour washout period when switching from an ACE inhibitor to sacubitril/valsartan to prevent life-threatening angioedema.

3Internalize essential ECG emergency patterns: de Winter T-waves and Wellens syndrome as proximal LAD equivalents, modified Sgarbossa criteria for STEMI in LBBB, and the strict contraindication of AV nodal blocking drugs in pre-excited atrial fibrillation.

4Know valvular intervention thresholds: aortic stenosis severe criteria (Vmax >=4 m/s, mean gradient >=40 mmHg, AVA <=1.0 cm2), Wilkins score <=8 for percutaneous balloon mitral commissurotomy, and COAPT trial criteria for transcatheter edge-to-edge repair (TEER) in secondary MR.

5Review secondary hypertension and vascular algorithms: ARR screening for primary aldosteronism followed by adrenal vein sampling, alpha-blockade prior to beta-blockade in pheochromocytoma, and Stanford A dissection immediate emergency surgical repair.

Frequently Asked Questions

Who is eligible to sit for the UKOM Sp.JP examination?

Candidates must complete an accredited Specialist-1 Cardiology and Vascular Medicine residency program and satisfy the Kolegium's current registration and study-program endorsement requirements. Exact sitting-specific eligibility documentation should be confirmed with the Kolegium and the candidate's PPDS program.

What is the format and structure of the official UKOM Sp.JP examination?

Current official sources confirm CBT and OSCE components. The June 2026 CBT was scheduled for three hours, but item count and OSCE station count were not published in the official sources reviewed.

Is this OpenExamPrep question bank an official examination resource?

No. This question bank is an independent English-language MCQ study adaptation developed by OpenExamPrep for self-study and clinical knowledge reinforcement. It is not affiliated with, authorized by, or endorsed by the Kolegium Jantung dan Pembuluh Darah Indonesia or KKI.

What curriculum and guidelines form the basis of the UKOM Sp.JP exam?

The examination scope is defined by Peraturan Konsil Kedokteran Indonesia (Perkonsil) No. 57 Tahun 2018 regarding the Education Standards for Cardiology and Vascular Medicine Specialists, reflecting clinical practice guidelines from the Indonesian Heart Association (PERKI), the Indonesian Society of Hypertension (PERHI), ESC, and ACC/AHA.

What happens if a candidate does not pass the UKOM Sp.JP on their first attempt?

Current component-level retake rules, timing, registration requirements, and fees were not published in the official sources reviewed; candidates should confirm them with Kolegium Jantung dan Pembuluh Darah Indonesia.

How long is the specialist registration certificate (STR Sp.JP) valid after passing?

Upon passing the UKOM Sp.JP and receiving the specialist certificate from Kolegium Jantung, the candidate registers with KKI for the Surat Tanda Registrasi (STR Dokter Spesialis). In Indonesia, medical registration is maintained through continuous professional development (P2KB) credits managed by PERKI and IDI.